Pharmabiz18h
Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target
Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target: Boston, Massachusetts Thursday ...
Pharmabiz1d
MTaI to host MedTekon 2025 in New Delhi on January 30
Our Bureau, New Delhi Wednesday, January 8, 2025, 09:00 Hrs [IST] Medical Technology Association of India (MTaI), which repr ...
Pharmabiz1d
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...
Pharmabiz13h
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck: Weston, Massachusetts Thursday, January 9, 2025, 18:00 Hrs [IST ...
Pharmabiz17h
US FDA clears Solid Biosciences’ IND application for SGT-212 to treat neurologic & cardiac manifestations of Friedreich’s ataxia
Charlestown, Massachusetts Thursday, January 9, 2025, 14:30 Hrs [IST] ...
Pharmabiz1d
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...
Pharmabiz16h
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams: Our Bureau, Bengaluru Thursday, January 9, 2025, 15:30 Hrs [IST] Eli Lilly an ...
Pharmabiz1d
Indian health sector navigating complexities of M&As: Harsh Vaish
Harsh Vaish: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] Mergers and Acquisitions (M&As) have ...
Pharmabiz2d
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary: Our Bureau, Mumbai Tuesday, January 7, 2025, 17:15 Hrs [IST] Zydus L ...
Pharmabiz15h
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins: Shanghai Thursday, January 9, 2025, 1 ...
Pharmabiz2d
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Pharmabiz17h
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications: San Diego Thursday, January 9, 2025, 14:00 ...